| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |